pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,414 catalysts · 6,086 phase readout · 2,322 8k filing · 400 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 73 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout6,086
  • 8k filing2,322
  • earnings400
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07351942: Effectiveness of Low-Load Resistance Training With Blood Flow Restriction in Lateral Epicondylitis

Sponsor: Sisli Hamidiye Etfal Training and Research Hospital. Phase: NA. Conditions: Lateral Epicondylitis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07734870: Tirzepatide for Treatment of CCCA

Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Central Centrifugal Cicatricial Alopecia (CCCA)

full page →ctgov ↗
›COMPLETEDphase readoutNCT06104670: The Effect of Synaquell™ in Contact Sport Athletes

Sponsor: Mayo Clinic. Phase: NA. Conditions: Healthy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06242470: A Study of MGC026 in Participants With Advanced Solid Tumors

Sponsor: MacroGenics. Phase: PHASE1. Conditions: Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer, Squamous Cell Carcinoma of Head and Neck, Non Small Cell Lung Cancer, Small-cell Lung Cancer, Bladder Cancer, Sarcoma, Endometrial Cancer, Melanoma, Castration Resistant Prostatic Cancer, Cervical Cancer, Colorectal Cancer, Gastric Cancer, Gastro-esophageal Cancer, Pancreas Cancer, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma, Platinum-resistant Ovarian Cancer, Breast Cancer, Ovarian Cancer, Esophageal Squamous Cell Cancer (SCC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06443970: Low and High Flow Suctioning in Intubated Infants

Sponsor: Columbia University. Phase: NA. Conditions: Respiratory Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT06956742: Intermittent Intrapulmonary Deflation and Dyspnea Following Exercise in People With Chronic Obstructive Pulmonary Disease

Sponsor: ADIR Association. Phase: NA. Conditions: Chronic Obstructive Pulmonary Disease (COPD)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07425886: Six-Month Therapeutic Program and Trunk Rotation in Girls Aged 8-11

Sponsor: Wioleta Chwalewska. Phase: NA. Conditions: Trunk Asymmetry in Children

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06850870: Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)

Sponsor: Onward Health, Inc. Phase: PHASE1. Conditions: Alzheimer Disease or Associated Disorder, Dementia, Cognitive Decline

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04781673: Ketamine vs Lidocaine in Traumatic Rib Fractures

Sponsor: Brittany Hoyte. Phase: PHASE4. Conditions: Rib Fractures, Rib Fracture Multiple, Rib Trauma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07316673: A Prospective Randomized Clinical Trial Comparing a Fast-Fix-Enhanced Arthroscopic System Versus Conventional Arthroscopic Suturing for Temporomandibular Disc Repositioning in Internal Derangement: Functional, Clinical, and Surgical Outcomes

Sponsor: Cairo University. Phase: NA. Conditions: Temporomandibular Joint Internal Derangement

full page →ctgov ↗
›RECRUITINGphase readoutNCT07481383: A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Sponsor: Continuity Biosciences, LLC. Phase: PHASE1. Conditions: Pancreatic Adenocarcinoma Non-resectable

full page →ctgov ↗
›RECRUITINGphase readoutNCT07578883: Scar Mobilization Improves Scars and Quality of Life in Burned Children.

Sponsor: Riphah International University. Phase: NA. Conditions: Burn Scar

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05224583: Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant

Sponsor: Methodist Health System. Phase: . Conditions: Polyomavirus Infections, BK Viremia, Liver Transplant Infection, Kidney Transplant Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT07010783: Respiratory Functions in Parkinson's Disease

Sponsor: Ankara University. Phase: . Conditions: Parkinson Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07483983: Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: PHASE2. Conditions: Metastatic/Locally Advanced Non-Small-Cell Lung Cancer, Metastatic/Locally Pancreatic Ductal Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06836141: Biomarkers for Cognitive Decline in Intracerebral Hemorrhage

Sponsor: Rush University Medical Center. Phase: . Conditions: Primary Intracerebral Hemorrhage

full page →ctgov ↗
›RECRUITINGphase readoutNCT06069141: Comparisons of Treatment Responses of Early Syphilis to Benzathine Penicillin G With or Without Doxycycline

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Early Syphilis, Latent, Serological Relapse After Treatment

full page →ctgov ↗
›COMPLETEDphase readoutNCT06329141: A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

Sponsor: Glaceum. Phase: PHASE2. Conditions: Parkinson Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05564754: Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation

Sponsor: Region Skane. Phase: NA. Conditions: Cardiac Arrest With Successful Resuscitation, Hypoxia, Brain

full page →ctgov ↗
›RECRUITINGphase readoutNCT05881005: NAC- NAFLD And Cushing

Sponsor: University Hospital, Angers. Phase: NA. Conditions: Cushing Syndrome, Fatty Liver Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT03927105: Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

Sponsor: University of Michigan Rogel Cancer Center. Phase: PHASE2. Conditions: Peripheral T Cell Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07288294: PRImary Care Strategies for Weight Management (PRISM) Study

Sponsor: Rush University Medical Center. Phase: NA. Conditions: Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07316166: Suprainguinal Fascia Iliaca Block With vs Without Dexmedetomidine

Sponsor: Rhode Island Hospital. Phase: PHASE4. Conditions: Postoperative Pain Management

full page →ctgov ↗
›COMPLETEDphase readoutNCT05880966: Functional Fitness for Overweight or Obese Adults With Mobility Disabilities

Sponsor: University of Kansas. Phase: NA. Conditions: Mobility Limitation, Overweight or Obesity, Physical Disability

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07681856: Immersive Physical Activity Program for Overweight Schoolchildren

Sponsor: University of Vigo. Phase: NA. Conditions: Childhood Overweight and Obesity Immersive Physical Activity

full page →ctgov ↗
›COMPLETEDphase readoutNCT05701956: Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion

Sponsor: The First Affiliated Hospital of University of Science and Technology of China. Phase: PHASE3. Conditions: Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion

full page →ctgov ↗
›COMPLETEDphase readoutNCT06480656: Eccentric Cycling Exercise During Pulmonary Rehabilitation Pulmonary Vascular Disease

Sponsor: University of Zurich. Phase: NA. Conditions: Eccentric Cycling Exercise

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07685756: Cervical Ripening Balloon Compared With Vaginal Misoprostol for Cervical Ripening in Obese Woman at Term

Sponsor: HUDDA Ahmad. Phase: NA. Conditions: Cervical Ripening

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05798156: Rituximab in Combination With Glofitamab and Polatuzumab Vedotin in Patients With Previously Untreated Aggressive B-cell Lymphoma Ineligible for R-CHOP

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest. Phase: PHASE2. Conditions: Lymphoma, Large B-Cell, Diffuse

full page →ctgov ↗
›RECRUITINGphase readoutNCT06040762: A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

Sponsor: University of Washington. Phase: NA. Conditions: Bladder Cancer, Urothelial Carcinoma, Upper Tract Urothelial Carcinoma, Renal Pelvis and Ureter Urothelial Carcinoma

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06005662: Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder

Sponsor: Johns Hopkins University. Phase: PHASE2. Conditions: Opioid Use Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT02104362: Single Fraction Early Prostate Irradiation (SiFEPI)

Sponsor: Centre Antoine Lacassagne. Phase: NA. Conditions: Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07483788: Short Term Comparative Assessment of MTA and Biodentine in Complete Pulpotomy for Symptomatic Irreversible Pulpitis

Sponsor: Dow University of Health Sciences. Phase: NA. Conditions: Symptomatic Irreversible Pulpitis (SIP)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03251027: Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. Phase: NA. Conditions: Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07344961: Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)

Sponsor: Northwell Health. Phase: . Conditions: Paroxysmal Atrial Fibrillation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05970042: Investigating the Effects of the "GameDay Ready" Behavioral Weight Management Program for Black Men Living in the Rural South

Sponsor: University of South Carolina. Phase: NA. Conditions: Obesity

full page →ctgov ↗
›TERMINATEDphase readoutNCT05416086: iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

Sponsor: Adagio Medical. Phase: NA. Conditions: Atrial Fibrillation, Atrial Flutter, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation

full page →ctgov ↗
›COMPLETEDphase readoutNCT06571370: Wave Crossover ECP Study for Simplified Therapy

Sponsor: Pression. Phase: NA. Conditions: Chronic Stable Angina, Refractory Angina

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03451370: First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer

Sponsor: Istituto Oncologico Veneto IRCCS. Phase: . Conditions: Elderly Metastatic Colorectal Cancer Patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT06778070: National Program to Overcome Pelvic Pain studY (POPPY)

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Chronic Pelvic Pain Syndrome (CPPS), Chronic Pelvic Pain Syndrome, Chronic Pelvic Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT05431270: Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

Sponsor: Phanes Therapeutics. Phase: PHASE1. Conditions: Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07093073: Clinical Study of U01(ssCART-19) in Patients With B-Cell Lymphoma

Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd. Phase: PHASE1. Conditions: B Cell Lymphoma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07294573: Maternal Health Assessment in Pediatric Care

Sponsor: John James Parker. Phase: NA. Conditions: Postpartum Care, Primary Care, Mental Health, Family Planning, Care Coordination

full page →ctgov ↗
›COMPLETEDphase readoutNCT07567573: Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery

Sponsor: European Society of Gynaecological Oncology. Phase: . Conditions: D010051, Ovarian Cancer, Advanced-stage Ovarian Cancer, FIGO Stages III and IV, Quality Indicators

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07545369: ULTRA-EVOLUT RCT: A Comparison of Latest-Generation TAVR Valves

Sponsor: Assiut University. Phase: NA. Conditions: Severe Aortic Valve Stenosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07531069: Efficacy and Safety of Interferon-Gamma Monoclonal Antibody Combined With Dexamethasone in the Treatment of Refractory Adult Secondary Hemophagocytic Lymphohistiocytosis

Sponsor: Fudan University. Phase: . Conditions: Adult Refractory Secondary Hemophagocytic Lymphohistiocytosis, Secondary Hemophagocytic Lymphohistiocytosis, HLH

full page →ctgov ↗
›COMPLETEDphase readoutNCT02975869: A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01983241: Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)

Sponsor: Grifols Therapeutics LLC. Phase: PHASE3. Conditions: Pulmonary Emphysema in Alpha-1 PI Deficiency

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07395154: Comparison of Integrated Neuromuscular Inhibition Technique (INIT) and Active Release Technique (ART) in Patients With Upper Trapezius Trigger Points

Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Myofascial Pain Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT04142905: Is Asthma in Subjects With Obstructive Sleep Apnoea (OSA) Due to Dysanapsis

Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust. Phase: . Conditions: Asthma, Obstructive Sleep Apnoea (OSA), Dysanapis

full page →ctgov ↗
← prev
page 165 of 169
next →